BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

530125

SAMRATPH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SAMRAT PHARMACHEM LTD. Share Price Update

As of the latest trading session, SAMRAT PHARMACHEM LTD. share price is currently at ₹ 323, which is down by ₹ -0.64 from its previous closing. Today, the stock has fluctuated between ₹ 323.00 and ₹ 324.90. Over the past year, SAMRAT PHARMACHEM LTD. has achieved a return of -16.77 %. In the last month alone, the return has been -13.67 %. Read More...

Investment Returns

Over 1 Month -13.67% Over 3 Months -13.86% Over 6 Months -15.69% Over 1 Year -16.77%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAMRAT PHARMACHEM LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    99.80

  • P/E Ratio (TTM)

    20.76

  • Beta

    0.67

  • Book Value / share

    232.38

  • Return on equity

    3.37%

  • EPS (TTM)

    15.59

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.23

info icon alternate text

SAMRAT PHARMACHEM LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 75.65
Operating Expense 76.14
Net Profit -0.23
Net Profit Margin (%) -0.30
Earnings Per Share (EPS) -0.74
EBITDA 0.82
Effective Tax Rate (%) 209.52
Particulars MAR 2025 (Values in Cr)
Revenue 71.20
Operating Expense 71.46
Net Profit -0.40
Net Profit Margin (%) -0.56
Earnings Per Share (EPS) -1.29
EBITDA 0.02
Effective Tax Rate (%) -11.11
Particulars DEC 2024 (Values in Cr)
Revenue 63.66
Operating Expense 59.76
Net Profit 2.78
Net Profit Margin (%) 4.36
Earnings Per Share (EPS) 9.01
EBITDA 4.18
Effective Tax Rate (%) 28.90
Particulars SEP 2024 (Values in Cr)
Revenue 70.17
Operating Expense 67.15
Net Profit 2.66
Net Profit Margin (%) 3.79
Earnings Per Share (EPS) 8.60
EBITDA 3.86
Effective Tax Rate (%) 24.43
Particulars JUN 2024 (Values in Cr)
Revenue 80.82
Operating Expense 78.59
Net Profit 2.07
Net Profit Margin (%) 2.56
Earnings Per Share (EPS) 6.68
EBITDA 3.17
Effective Tax Rate (%) 26.59
Particulars MAR 2025 (Values in Cr)
Revenue 285.86
Operating Expense 276.94
Net Profit 7.11
Net Profit Margin (%) 2.48
Earnings Per Share (EPS) 23.02
EBITDA 11.21
Effective Tax Rate (%) 28.00
Particulars MAR 2024 (Values in Cr)
Revenue 281.58
Operating Expense 280.45
Net Profit 2.16
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 7.00
EBITDA 3.86
Effective Tax Rate (%) 14.28
Particulars MAR 2023 (Values in Cr)
Revenue 310.65
Operating Expense 288.59
Net Profit 16.63
Net Profit Margin (%) 5.35
Earnings Per Share (EPS) 53.83
EBITDA 24.40
Effective Tax Rate (%) 26.18
Particulars MAR 2022 (Values in Cr)
Revenue 221.75
Operating Expense 198.78
Net Profit 17.18
Net Profit Margin (%) 7.74
Earnings Per Share (EPS) 55.62
EBITDA 24.86
Effective Tax Rate (%) 27.20
Particulars MAR 2021 (Values in Cr)
Revenue 179.02
Operating Expense 172.12
Net Profit 5.33
Net Profit Margin (%) 2.97
Earnings Per Share (EPS) 17.26
EBITDA 9.11
Effective Tax Rate (%) 27.38
Particulars MAR 2024 (Values in Cr)
Book Value / Share 210.37
ROE % 3.37
ROCE % 4.14
Total Debt to Total Equity 0.21
EBITDA Margin 1.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 204.37
ROE % 30.25
ROCE % 34.91
Total Debt to Total Equity 0.24
EBITDA Margin 7.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 151.54
ROE % 44.94
ROCE % 52.32
Total Debt to Total Equity 0.21
EBITDA Margin 11.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 95.92
ROE % 19.76
ROCE % 23.90
Total Debt to Total Equity 0.34
EBITDA Margin 4.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.66
ROE % 19.11
ROCE % 22.38
Total Debt to Total Equity 0.36
EBITDA Margin 4.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.72
Total Assets 121.73
Total Liabilities 121.73
Total Equity 64.99
Share Outstanding 3089700
Price to Book Ratio 1.59
Return on Assets (%) 1.77
Return on Capital (%) 2.94
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.89
Total Assets 116.58
Total Liabilities 116.58
Total Equity 63.14
Share Outstanding 3089700
Price to Book Ratio 1.82
Return on Assets (%) 14.26
Return on Capital (%) 20.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.70
Total Assets 84.61
Total Liabilities 84.61
Total Equity 46.82
Share Outstanding 3089700
Price to Book Ratio 3.20
Return on Assets (%) 20.31
Return on Capital (%) 31.62
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.50
Total Assets 57.39
Total Liabilities 57.39
Total Equity 29.63
Share Outstanding 3089700
Price to Book Ratio 1.42
Return on Assets (%) 9.29
Return on Capital (%) 13.88
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.17
Total Assets 58.34
Total Liabilities 58.34
Total Equity 24.30
Share Outstanding 3089700
Price to Book Ratio 0.76
Return on Assets (%) 7.26
Return on Capital (%) 12.68
Particulars MAR 2024 (Values in Cr)
Net Income 2.52
Cash from Operations 11.82
Cash from Investing -0.40
Cash from Financing -11.20
Net change in Cash -2.19
Free Cash Flow 12.48
Particulars MAR 2023 (Values in Cr)
Net Income 22.53
Cash from Operations 0.06
Cash from Investing -3.00
Cash from Financing 9.59
Net change in Cash -2.84
Free Cash Flow 1.52
Particulars MAR 2022 (Values in Cr)
Net Income 23.60
Cash from Operations 19.00
Cash from Investing -1.06
Cash from Financing -1.94
Net change in Cash 14.46
Free Cash Flow 20.28
Particulars MAR 2021 (Values in Cr)
Net Income 7.34
Cash from Operations 7.05
Cash from Investing -2.92
Cash from Financing -1.88
Net change in Cash -0.01
Free Cash Flow 9.78
Particulars MAR 2020 (Values in Cr)
Net Income 5.78
Cash from Operations -0.45
Cash from Investing -1.92
Cash from Financing 2.00
Net change in Cash -1.24
Free Cash Flow 0.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 13.97 1.87 262.24 30.00 / 69.75
BLISS GVS PHARMA LTD 166.55 16.47 1.67 1757.06 105.05 / 190.65
CIPLA LTD 1545.85 23.16 4.00 124866.66 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 342.40 9.64 2.77 1007.72 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2785.40 49.83 24.18 47186.36 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 18.60 5.40 262.24 30.00 / 69.75
AMRUTAJAN HEALTH LTD 722.05 38.28 6.39 2087.49 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8450.65 99.90 27.42 21126.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 166.55 24.90 1.65 1757.06 105.05 / 190.65

SAMRAT PHARMACHEM LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
323.00 -0.20 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 324.20
  • 26 Days 340.30
  • 10 Days 328.80
  • 50 Days 347.50
  • 12 Days 330.70
  • 100 Days 354.60
  • 20 Days 336.90
  • 200 Days 367.80
321.15 PIVOT

First Support

316.35

First Resistance

324.30

Second Support

313.20

Second Resistance

329.10

Third Support

308.40

Third Resistance

332.25

RSI

34.30

ADX

47.84

MACD

-9.61

Williams % R

-88.75

Commodity Channel Index (CCI)

-132.64

Date

2025-08-20

Week

3074.00

Same Day

2268.00

Month

1788.00

1 Year

0.68

3 Year

0.55

Over 1 Month

-13.67%

down

Over 1 Year

-16.77%

down

Over 3 Months

-13.86%

down

Over 3 Years

-22.77%

down

Over 6 Months

-15.69%

down

Over 5 Years

25.40%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

SAMRAT PHARMACHEM LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

SAMRAT PHARMACHEM LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 1.0 Final 18 Sep 2025 Equity shares
19 Sep 2024 1.0 Final 19 Sep 2024 Equity shares
18 Sep 2023 1.0 Final 18 Sep 2023 Equity shares
22 Sep 2022 1.0 Final 23 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SAMRAT PHARMACHEM LTD. Share Price

Samrat Pharmachem Limited was incorporated on June 16, 1992. The Company's principal activities are manufacturing and selling chemicals.

The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Samrat Pharmachem Ltd?

Answer Field

Samrat Pharmachem Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 323.00 as on Aug 22 2025 03:25 PM.

What is the Market Cap of Samrat Pharmachem Ltd Share?

Answer Field

The market cap of Samrat Pharmachem Ltd for NSE ₹ 0.00 & for BSE ₹ 99.80 as on Aug 22 2025 03:25 PM.

What is the 52 Week High and Low of Samrat Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Samrat Pharmachem Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 646.00 and ₹ 302.05.

What is 1 year return for Samrat Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been -19.51%.

What is the P/E Ratio of Samrat Pharmachem Ltd Share?

Answer Field

As on Aug 22 2025 03:25 PM the price-to-earnings (PE) ratio for Samrat Pharmachem Ltd share is 20.76.

What is the PB ratio of Samrat Pharmachem Ltd Share?

Answer Field

As on Aug 22 2025 03:25 PM, the price-to-book (PB) ratio for Samrat Pharmachem Ltd share is 232.38.

How to Buy Samrat Pharmachem Ltd Share?

Answer Field

You can trade in Samrat Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Samrat Pharmachem Ltd Share on Bajaj Broking App?

Answer Field

To buy Samrat Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Samrat Pharmachem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91